#18: LIXT Stock News : Lixte Biotechnology Holdings' Lead Compound, LB-1.2, Enhances the Effectiveness of Standard Cancer Chemotherapy in Animal Models
EAST SETAUKET, N.Y., July 2
/PRNewswire-FirstCall/ -- Lixte Biotechnology Holdings (OTC Bulletin
Board: LIXT) announced today that investigators of the National
Institute of Neurological...
Lixte Biotechnology (LIXT.OB) was founded as a diagnostics company in 2005 evaluating biomarkers (indicators of disease at the molecular level), but has shifted its focus to become a cancer drug...
Washington, Oct 25 (ANI): In a new study, researchers at
Cedars-Sinai Medical Center’’s Maxine Dunitz Neurosurgical Institute
have discovered a molecular mechanism involved in the development of...
EAST SETAUKET, N.Y., Oct. 20 /PRNewswire-FirstCall/ -- John S. Kovach,
M.D., Chair, Board of Directors and CEO of Lixte Biotechnology Holdings, Inc.
(OTC Bulletin Board: LIXT stock), announces...
EAST SETAUKET, N.Y., Oct. 20 /PRNewswire-FirstCall/ -- John S. Kovach,
M.D., Chair, Board of Directors and CEO of Lixte Biotechnology Holdings, Inc.
(OTC...
by Harlan Spector Wednesday September 24, 2008, 8:22 PM
Monteris.comWatch a video that demonstrates the procedure.Two
Cleveland hospitals are embarking on an experimental procedure using
...
Sometimes it's the little things, stuff they once overlooked, that get their attention.
Like the cardinal hopping along the roadway, just a few feet in front of them.
Or a beautiful,...
EDISON —Jeffrey Weinstein is running a race against time.In July 2007, the 51-year-old township resident was diagnosed with a
form of brain tumor, (Glioblastoma Multiforme Grade IV brain tumor)
...
We need to stop this cancer. I hope Lixte Biotechnology, Inc. is a cure.Lixte Biotechnology Holdings, Inc. (Lixte) is
a cancer therapeutics and diagnostics company dedicated to bringing
...
LIXT might be a THE solution. This companys board of advisers has credibility. Let us hope they deliver a cure for those that have glioblastoma multiforme (GBM).The following is from...
About Lixte Biotechnology Holdings, Inc.:
Lixte Biotechnology Holdings, Inc. is a cancer therapeutics and
diagnostics company. Founded as a biomarker-diagnostics company in
2005, Lixte develops...
#5: Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases
EAST SETAUKET, N.Y., Aug. 12 /PRNewswire-FirstCall/ -- Lixte Biotechnology
Holdings, Inc. (OTC Bulletin Board: LIXT) announced today that it had filed a
patent...
#4: Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
EAST SETAUKET, N.Y., Aug. 8 /PRNewswire-FirstCall/ -- Lixte Biotechnology
Holdings, Inc. (OTC Bulletin Board: LIXT) announced today that lead compounds
from each...
